Global TACE Embolic Microspheres Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
TACE embolic microspheres are a type of microsphere embolic agent used in transcatheter arterial chemoembolization (TACE) therapy. TACE stands for Transarterial Chemoembolization, which is a medical procedure used primarily in the treatment of liver cancer. It involves delivering chemotherapy drugs directly to a tumor in the liver while also blocking the blood supply to the tumor. This dual action helps to both directly attack the cancer cells and cut off their blood supply, thereby shrinking or slowing the tumor's growth. TACE embolic microspheres can be loaded with chemotherapy drugs (such as doxorubicin) or used alone to embolize (block) the blood vessels. By blocking these vessels, the microspheres prevent the tumor from receiving oxygen and nutrients, thereby reducing its ability to grow and survive.
The global TACE Embolic Microspheres market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “TACE Embolic Microspheres Industry Forecast” looks at past sales and reviews total world TACE Embolic Microspheres sales in 2023, providing a comprehensive analysis by region and market sector of projected TACE Embolic Microspheres sales for 2024 through 2030. With TACE Embolic Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TACE Embolic Microspheres industry.
This Insight Report provides a comprehensive analysis of the global TACE Embolic Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TACE Embolic Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TACE Embolic Microspheres market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TACE Embolic Microspheres and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TACE Embolic Microspheres.
United States market for TACE Embolic Microspheres is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TACE Embolic Microspheres is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TACE Embolic Microspheres is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TACE Embolic Microspheres players cover Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TACE Embolic Microspheres market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global TACE Embolic Microspheres market?
What factors are driving TACE Embolic Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TACE Embolic Microspheres market opportunities vary by end market size?
How does TACE Embolic Microspheres break out by Type, by Application?
TACE embolic microspheres are a type of microsphere embolic agent used in transcatheter arterial chemoembolization (TACE) therapy. TACE stands for Transarterial Chemoembolization, which is a medical procedure used primarily in the treatment of liver cancer. It involves delivering chemotherapy drugs directly to a tumor in the liver while also blocking the blood supply to the tumor. This dual action helps to both directly attack the cancer cells and cut off their blood supply, thereby shrinking or slowing the tumor's growth. TACE embolic microspheres can be loaded with chemotherapy drugs (such as doxorubicin) or used alone to embolize (block) the blood vessels. By blocking these vessels, the microspheres prevent the tumor from receiving oxygen and nutrients, thereby reducing its ability to grow and survive.
The global TACE Embolic Microspheres market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “TACE Embolic Microspheres Industry Forecast” looks at past sales and reviews total world TACE Embolic Microspheres sales in 2023, providing a comprehensive analysis by region and market sector of projected TACE Embolic Microspheres sales for 2024 through 2030. With TACE Embolic Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TACE Embolic Microspheres industry.
This Insight Report provides a comprehensive analysis of the global TACE Embolic Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TACE Embolic Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TACE Embolic Microspheres market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TACE Embolic Microspheres and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TACE Embolic Microspheres.
United States market for TACE Embolic Microspheres is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TACE Embolic Microspheres is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TACE Embolic Microspheres is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TACE Embolic Microspheres players cover Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TACE Embolic Microspheres market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Common Embolic Microspheres
- Drug-Loadable Embolic Microspheres
- Primary Liver Cancer
- Colorectal Cancer Liver Metastasis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boston Scientific
- Terumo
- Merit Medical
- Varian
- Sirtex Medical
- Suzhou Hengrui Medical Equipment
- ABK Biomedical
- Mermaid Medical
- Cardiolink Science
What is the 10-year outlook for the global TACE Embolic Microspheres market?
What factors are driving TACE Embolic Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TACE Embolic Microspheres market opportunities vary by end market size?
How does TACE Embolic Microspheres break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TACE Embolic Microspheres Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TACE Embolic Microspheres by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TACE Embolic Microspheres by Country/Region, 2019, 2023 & 2030
2.2 TACE Embolic Microspheres Segment by Type
2.2.1 Common Embolic Microspheres
2.2.2 Drug-Loadable Embolic Microspheres
2.3 TACE Embolic Microspheres Sales by Type
2.3.1 Global TACE Embolic Microspheres Sales Market Share by Type (2019-2024)
2.3.2 Global TACE Embolic Microspheres Revenue and Market Share by Type (2019-2024)
2.3.3 Global TACE Embolic Microspheres Sale Price by Type (2019-2024)
2.4 TACE Embolic Microspheres Segment by Application
2.4.1 Primary Liver Cancer
2.4.2 Colorectal Cancer Liver Metastasis
2.4.3 Others
2.5 TACE Embolic Microspheres Sales by Application
2.5.1 Global TACE Embolic Microspheres Sale Market Share by Application (2019-2024)
2.5.2 Global TACE Embolic Microspheres Revenue and Market Share by Application (2019-2024)
2.5.3 Global TACE Embolic Microspheres Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global TACE Embolic Microspheres Breakdown Data by Company
3.1.1 Global TACE Embolic Microspheres Annual Sales by Company (2019-2024)
3.1.2 Global TACE Embolic Microspheres Sales Market Share by Company (2019-2024)
3.2 Global TACE Embolic Microspheres Annual Revenue by Company (2019-2024)
3.2.1 Global TACE Embolic Microspheres Revenue by Company (2019-2024)
3.2.2 Global TACE Embolic Microspheres Revenue Market Share by Company (2019-2024)
3.3 Global TACE Embolic Microspheres Sale Price by Company
3.4 Key Manufacturers TACE Embolic Microspheres Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TACE Embolic Microspheres Product Location Distribution
3.4.2 Players TACE Embolic Microspheres Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TACE EMBOLIC MICROSPHERES BY GEOGRAPHIC REGION
4.1 World Historic TACE Embolic Microspheres Market Size by Geographic Region (2019-2024)
4.1.1 Global TACE Embolic Microspheres Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TACE Embolic Microspheres Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TACE Embolic Microspheres Market Size by Country/Region (2019-2024)
4.2.1 Global TACE Embolic Microspheres Annual Sales by Country/Region (2019-2024)
4.2.2 Global TACE Embolic Microspheres Annual Revenue by Country/Region (2019-2024)
4.3 Americas TACE Embolic Microspheres Sales Growth
4.4 APAC TACE Embolic Microspheres Sales Growth
4.5 Europe TACE Embolic Microspheres Sales Growth
4.6 Middle East & Africa TACE Embolic Microspheres Sales Growth
5 AMERICAS
5.1 Americas TACE Embolic Microspheres Sales by Country
5.1.1 Americas TACE Embolic Microspheres Sales by Country (2019-2024)
5.1.2 Americas TACE Embolic Microspheres Revenue by Country (2019-2024)
5.2 Americas TACE Embolic Microspheres Sales by Type (2019-2024)
5.3 Americas TACE Embolic Microspheres Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TACE Embolic Microspheres Sales by Region
6.1.1 APAC TACE Embolic Microspheres Sales by Region (2019-2024)
6.1.2 APAC TACE Embolic Microspheres Revenue by Region (2019-2024)
6.2 APAC TACE Embolic Microspheres Sales by Type (2019-2024)
6.3 APAC TACE Embolic Microspheres Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TACE Embolic Microspheres by Country
7.1.1 Europe TACE Embolic Microspheres Sales by Country (2019-2024)
7.1.2 Europe TACE Embolic Microspheres Revenue by Country (2019-2024)
7.2 Europe TACE Embolic Microspheres Sales by Type (2019-2024)
7.3 Europe TACE Embolic Microspheres Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TACE Embolic Microspheres by Country
8.1.1 Middle East & Africa TACE Embolic Microspheres Sales by Country (2019-2024)
8.1.2 Middle East & Africa TACE Embolic Microspheres Revenue by Country (2019-2024)
8.2 Middle East & Africa TACE Embolic Microspheres Sales by Type (2019-2024)
8.3 Middle East & Africa TACE Embolic Microspheres Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TACE Embolic Microspheres
10.3 Manufacturing Process Analysis of TACE Embolic Microspheres
10.4 Industry Chain Structure of TACE Embolic Microspheres
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TACE Embolic Microspheres Distributors
11.3 TACE Embolic Microspheres Customer
12 WORLD FORECAST REVIEW FOR TACE EMBOLIC MICROSPHERES BY GEOGRAPHIC REGION
12.1 Global TACE Embolic Microspheres Market Size Forecast by Region
12.1.1 Global TACE Embolic Microspheres Forecast by Region (2025-2030)
12.1.2 Global TACE Embolic Microspheres Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global TACE Embolic Microspheres Forecast by Type (2025-2030)
12.7 Global TACE Embolic Microspheres Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific TACE Embolic Microspheres Product Portfolios and Specifications
13.1.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Terumo
13.2.1 Terumo Company Information
13.2.2 Terumo TACE Embolic Microspheres Product Portfolios and Specifications
13.2.3 Terumo TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Terumo Main Business Overview
13.2.5 Terumo Latest Developments
13.3 Merit Medical
13.3.1 Merit Medical Company Information
13.3.2 Merit Medical TACE Embolic Microspheres Product Portfolios and Specifications
13.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merit Medical Main Business Overview
13.3.5 Merit Medical Latest Developments
13.4 Varian
13.4.1 Varian Company Information
13.4.2 Varian TACE Embolic Microspheres Product Portfolios and Specifications
13.4.3 Varian TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Varian Main Business Overview
13.4.5 Varian Latest Developments
13.5 Sirtex Medical
13.5.1 Sirtex Medical Company Information
13.5.2 Sirtex Medical TACE Embolic Microspheres Product Portfolios and Specifications
13.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sirtex Medical Main Business Overview
13.5.5 Sirtex Medical Latest Developments
13.6 Suzhou Hengrui Medical Equipment
13.6.1 Suzhou Hengrui Medical Equipment Company Information
13.6.2 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolios and Specifications
13.6.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Suzhou Hengrui Medical Equipment Main Business Overview
13.6.5 Suzhou Hengrui Medical Equipment Latest Developments
13.7 ABK Biomedical
13.7.1 ABK Biomedical Company Information
13.7.2 ABK Biomedical TACE Embolic Microspheres Product Portfolios and Specifications
13.7.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 ABK Biomedical Main Business Overview
13.7.5 ABK Biomedical Latest Developments
13.8 Mermaid Medical
13.8.1 Mermaid Medical Company Information
13.8.2 Mermaid Medical TACE Embolic Microspheres Product Portfolios and Specifications
13.8.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mermaid Medical Main Business Overview
13.8.5 Mermaid Medical Latest Developments
13.9 Cardiolink Science
13.9.1 Cardiolink Science Company Information
13.9.2 Cardiolink Science TACE Embolic Microspheres Product Portfolios and Specifications
13.9.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cardiolink Science Main Business Overview
13.9.5 Cardiolink Science Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1.TACE Embolic Microspheres Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2.TACE Embolic Microspheres Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Common Embolic Microspheres
Table 4. Major Players of Drug-Loadable Embolic Microspheres
Table 5. GlobalTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 6. GlobalTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Table 7. GlobalTACE Embolic Microspheres Revenue byType (2019-2024) & ($ million)
Table 8. GlobalTACE Embolic Microspheres Revenue Market Share byType (2019-2024)
Table 9. GlobalTACE Embolic Microspheres Sale Price byType (2019-2024) & (US$/Unit)
Table 10. GlobalTACE Embolic Microspheres Sale by Application (2019-2024) & (K Units)
Table 11. GlobalTACE Embolic Microspheres Sale Market Share by Application (2019-2024)
Table 12. GlobalTACE Embolic Microspheres Revenue by Application (2019-2024) & ($ million)
Table 13. GlobalTACE Embolic Microspheres Revenue Market Share by Application (2019-2024)
Table 14. GlobalTACE Embolic Microspheres Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. GlobalTACE Embolic Microspheres Sales by Company (2019-2024) & (K Units)
Table 16. GlobalTACE Embolic Microspheres Sales Market Share by Company (2019-2024)
Table 17. GlobalTACE Embolic Microspheres Revenue by Company (2019-2024) & ($ millions)
Table 18. GlobalTACE Embolic Microspheres Revenue Market Share by Company (2019-2024)
Table 19. GlobalTACE Embolic Microspheres Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key ManufacturersTACE Embolic Microspheres Producing Area Distribution and Sales Area
Table 21. PlayersTACE Embolic Microspheres Products Offered
Table 22.TACE Embolic Microspheres Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalTACE Embolic Microspheres Sales by Geographic Region (2019-2024) & (K Units)
Table 26. GlobalTACE Embolic Microspheres Sales Market Share Geographic Region (2019-2024)
Table 27. GlobalTACE Embolic Microspheres Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. GlobalTACE Embolic Microspheres Revenue Market Share by Geographic Region (2019-2024)
Table 29. GlobalTACE Embolic Microspheres Sales by Country/Region (2019-2024) & (K Units)
Table 30. GlobalTACE Embolic Microspheres Sales Market Share by Country/Region (2019-2024)
Table 31. GlobalTACE Embolic Microspheres Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. GlobalTACE Embolic Microspheres Revenue Market Share by Country/Region (2019-2024)
Table 33. AmericasTACE Embolic Microspheres Sales by Country (2019-2024) & (K Units)
Table 34. AmericasTACE Embolic Microspheres Sales Market Share by Country (2019-2024)
Table 35. AmericasTACE Embolic Microspheres Revenue by Country (2019-2024) & ($ millions)
Table 36. AmericasTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 37. AmericasTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 38. APACTACE Embolic Microspheres Sales by Region (2019-2024) & (K Units)
Table 39. APACTACE Embolic Microspheres Sales Market Share by Region (2019-2024)
Table 40. APACTACE Embolic Microspheres Revenue by Region (2019-2024) & ($ millions)
Table 41. APACTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 42. APACTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 43. EuropeTACE Embolic Microspheres Sales by Country (2019-2024) & (K Units)
Table 44. EuropeTACE Embolic Microspheres Revenue by Country (2019-2024) & ($ millions)
Table 45. EuropeTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 46. EuropeTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & AfricaTACE Embolic Microspheres Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & AfricaTACE Embolic Microspheres Revenue Market Share by Country (2019-2024)
Table 49. Middle East & AfricaTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 50. Middle East & AfricaTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities ofTACE Embolic Microspheres
Table 52. Key Market Challenges & Risks ofTACE Embolic Microspheres
Table 53. Key IndustryTrends ofTACE Embolic Microspheres
Table 54.TACE Embolic Microspheres Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.TACE Embolic Microspheres Distributors List
Table 57.TACE Embolic Microspheres Customer List
Table 58. GlobalTACE Embolic Microspheres SalesForecast by Region (2025-2030) & (K Units)
Table 59. GlobalTACE Embolic Microspheres RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. AmericasTACE Embolic Microspheres SalesForecast by Country (2025-2030) & (K Units)
Table 61. AmericasTACE Embolic Microspheres Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APACTACE Embolic Microspheres SalesForecast by Region (2025-2030) & (K Units)
Table 63. APACTACE Embolic Microspheres Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. EuropeTACE Embolic Microspheres SalesForecast by Country (2025-2030) & (K Units)
Table 65. EuropeTACE Embolic Microspheres RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & AfricaTACE Embolic Microspheres SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & AfricaTACE Embolic Microspheres RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. GlobalTACE Embolic Microspheres SalesForecast byType (2025-2030) & (K Units)
Table 69. GlobalTACE Embolic Microspheres RevenueForecast byType (2025-2030) & ($ millions)
Table 70. GlobalTACE Embolic Microspheres SalesForecast by Application (2025-2030) & (K Units)
Table 71. GlobalTACE Embolic Microspheres RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Boston Scientific Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 73. Boston ScientificTACE Embolic Microspheres Product Portfolios and Specifications
Table 74. Boston ScientificTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Boston Scientific Main Business
Table 76. Boston Scientific Latest Developments
Table 77.Terumo Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 78.TerumoTACE Embolic Microspheres Product Portfolios and Specifications
Table 79.TerumoTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80.Terumo Main Business
Table 81.Terumo Latest Developments
Table 82. Merit Medical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 83. Merit MedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 84. Merit MedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Merit Medical Main Business
Table 86. Merit Medical Latest Developments
Table 87. Varian Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 88. VarianTACE Embolic Microspheres Product Portfolios and Specifications
Table 89. VarianTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Varian Main Business
Table 91. Varian Latest Developments
Table 92. Sirtex Medical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 93. Sirtex MedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 94. Sirtex MedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sirtex Medical Main Business
Table 96. Sirtex Medical Latest Developments
Table 97. Suzhou Hengrui Medical Equipment Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 98. Suzhou Hengrui Medical EquipmentTACE Embolic Microspheres Product Portfolios and Specifications
Table 99. Suzhou Hengrui Medical EquipmentTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Suzhou Hengrui Medical Equipment Main Business
Table 101. Suzhou Hengrui Medical Equipment Latest Developments
Table 102. ABK Biomedical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 103. ABK BiomedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 104. ABK BiomedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. ABK Biomedical Main Business
Table 106. ABK Biomedical Latest Developments
Table 107. Mermaid Medical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 108. Mermaid MedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 109. Mermaid MedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Mermaid Medical Main Business
Table 111. Mermaid Medical Latest Developments
Table 112. Cardiolink Science Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 113. Cardiolink ScienceTACE Embolic Microspheres Product Portfolios and Specifications
Table 114. Cardiolink ScienceTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Cardiolink Science Main Business
Table 116. Cardiolink Science Latest Developments
LIST OFFIGURES
.
Figure 1. Picture ofTACE Embolic Microspheres
Figure 2.TACE Embolic Microspheres Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTACE Embolic Microspheres Sales Growth Rate 2019-2030 (K Units)
Figure 7. GlobalTACE Embolic Microspheres Revenue Growth Rate 2019-2030 ($ millions)
Figure 8.TACE Embolic Microspheres Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9.TACE Embolic Microspheres Sales Market Share by Country/Region (2023)
Figure 10.TACE Embolic Microspheres Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Common Embolic Microspheres
Figure 12. Product Picture of Drug-Loadable Embolic Microspheres
Figure 13. GlobalTACE Embolic Microspheres Sales Market Share byType in 2023
Figure 14. GlobalTACE Embolic Microspheres Revenue Market Share byType (2019-2024)
Figure 15.TACE Embolic Microspheres Consumed in Primary Liver Cancer
Figure 16. GlobalTACE Embolic Microspheres Market: Primary Liver Cancer (2019-2024) & (K Units)
Figure 17.TACE Embolic Microspheres Consumed in Colorectal Cancer Liver Metastasis
Figure 18. GlobalTACE Embolic Microspheres Market: Colorectal Cancer Liver Metastasis (2019-2024) & (K Units)
Figure 19.TACE Embolic Microspheres Consumed in Others
Figure 20. GlobalTACE Embolic Microspheres Market: Others (2019-2024) & (K Units)
Figure 21. GlobalTACE Embolic Microspheres Sale Market Share by Application (2023)
Figure 22. GlobalTACE Embolic Microspheres Revenue Market Share by Application in 2023
Figure 23.TACE Embolic Microspheres Sales by Company in 2023 (K Units)
Figure 24. GlobalTACE Embolic Microspheres Sales Market Share by Company in 2023
Figure 25.TACE Embolic Microspheres Revenue by Company in 2023 ($ millions)
Figure 26. GlobalTACE Embolic Microspheres Revenue Market Share by Company in 2023
Figure 27. GlobalTACE Embolic Microspheres Sales Market Share by Geographic Region (2019-2024)
Figure 28. GlobalTACE Embolic Microspheres Revenue Market Share by Geographic Region in 2023
Figure 29. AmericasTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 30. AmericasTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 31. APACTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 32. APACTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 33. EuropeTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 34. EuropeTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 35. Middle East & AfricaTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 36. Middle East & AfricaTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 37. AmericasTACE Embolic Microspheres Sales Market Share by Country in 2023
Figure 38. AmericasTACE Embolic Microspheres Revenue Market Share by Country (2019-2024)
Figure 39. AmericasTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 40. AmericasTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 41. United StatesTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 42. CanadaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 43. MexicoTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 44. BrazilTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 45. APACTACE Embolic Microspheres Sales Market Share by Region in 2023
Figure 46. APACTACE Embolic Microspheres Revenue Market Share by Region (2019-2024)
Figure 47. APACTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 48. APACTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 49. ChinaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 50. JapanTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 51. South KoreaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast AsiaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 53. IndiaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 54. AustraliaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwanTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 56. EuropeTACE Embolic Microspheres Sales Market Share by Country in 2023
Figure 57. EuropeTACE Embolic Microspheres Revenue Market Share by Country (2019-2024)
Figure 58. EuropeTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 59. EuropeTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 60. GermanyTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 61.FranceTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 62. UKTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 63. ItalyTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 64. RussiaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & AfricaTACE Embolic Microspheres Sales Market Share by Country (2019-2024)
Figure 66. Middle East & AfricaTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 67. Middle East & AfricaTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 68. EgyptTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 69. South AfricaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 70. IsraelTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 71.TurkeyTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC CountriesTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofTACE Embolic Microspheres in 2023
Figure 74. Manufacturing Process Analysis ofTACE Embolic Microspheres
Figure 75. Industry Chain Structure ofTACE Embolic Microspheres
Figure 76. Channels of Distribution
Figure 77. GlobalTACE Embolic Microspheres Sales MarketForecast by Region (2025-2030)
Figure 78. GlobalTACE Embolic Microspheres Revenue Market ShareForecast by Region (2025-2030)
Figure 79. GlobalTACE Embolic Microspheres Sales Market ShareForecast byType (2025-2030)
Figure 80. GlobalTACE Embolic Microspheres Revenue Market ShareForecast byType (2025-2030)
Figure 81. GlobalTACE Embolic Microspheres Sales Market ShareForecast by Application (2025-2030)
Figure 82. GlobalTACE Embolic Microspheres Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TACE Embolic Microspheres Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for TACE Embolic Microspheres by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for TACE Embolic Microspheres by Country/Region, 2019, 2023 & 2030
2.2 TACE Embolic Microspheres Segment by Type
2.2.1 Common Embolic Microspheres
2.2.2 Drug-Loadable Embolic Microspheres
2.3 TACE Embolic Microspheres Sales by Type
2.3.1 Global TACE Embolic Microspheres Sales Market Share by Type (2019-2024)
2.3.2 Global TACE Embolic Microspheres Revenue and Market Share by Type (2019-2024)
2.3.3 Global TACE Embolic Microspheres Sale Price by Type (2019-2024)
2.4 TACE Embolic Microspheres Segment by Application
2.4.1 Primary Liver Cancer
2.4.2 Colorectal Cancer Liver Metastasis
2.4.3 Others
2.5 TACE Embolic Microspheres Sales by Application
2.5.1 Global TACE Embolic Microspheres Sale Market Share by Application (2019-2024)
2.5.2 Global TACE Embolic Microspheres Revenue and Market Share by Application (2019-2024)
2.5.3 Global TACE Embolic Microspheres Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global TACE Embolic Microspheres Breakdown Data by Company
3.1.1 Global TACE Embolic Microspheres Annual Sales by Company (2019-2024)
3.1.2 Global TACE Embolic Microspheres Sales Market Share by Company (2019-2024)
3.2 Global TACE Embolic Microspheres Annual Revenue by Company (2019-2024)
3.2.1 Global TACE Embolic Microspheres Revenue by Company (2019-2024)
3.2.2 Global TACE Embolic Microspheres Revenue Market Share by Company (2019-2024)
3.3 Global TACE Embolic Microspheres Sale Price by Company
3.4 Key Manufacturers TACE Embolic Microspheres Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TACE Embolic Microspheres Product Location Distribution
3.4.2 Players TACE Embolic Microspheres Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TACE EMBOLIC MICROSPHERES BY GEOGRAPHIC REGION
4.1 World Historic TACE Embolic Microspheres Market Size by Geographic Region (2019-2024)
4.1.1 Global TACE Embolic Microspheres Annual Sales by Geographic Region (2019-2024)
4.1.2 Global TACE Embolic Microspheres Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic TACE Embolic Microspheres Market Size by Country/Region (2019-2024)
4.2.1 Global TACE Embolic Microspheres Annual Sales by Country/Region (2019-2024)
4.2.2 Global TACE Embolic Microspheres Annual Revenue by Country/Region (2019-2024)
4.3 Americas TACE Embolic Microspheres Sales Growth
4.4 APAC TACE Embolic Microspheres Sales Growth
4.5 Europe TACE Embolic Microspheres Sales Growth
4.6 Middle East & Africa TACE Embolic Microspheres Sales Growth
5 AMERICAS
5.1 Americas TACE Embolic Microspheres Sales by Country
5.1.1 Americas TACE Embolic Microspheres Sales by Country (2019-2024)
5.1.2 Americas TACE Embolic Microspheres Revenue by Country (2019-2024)
5.2 Americas TACE Embolic Microspheres Sales by Type (2019-2024)
5.3 Americas TACE Embolic Microspheres Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TACE Embolic Microspheres Sales by Region
6.1.1 APAC TACE Embolic Microspheres Sales by Region (2019-2024)
6.1.2 APAC TACE Embolic Microspheres Revenue by Region (2019-2024)
6.2 APAC TACE Embolic Microspheres Sales by Type (2019-2024)
6.3 APAC TACE Embolic Microspheres Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TACE Embolic Microspheres by Country
7.1.1 Europe TACE Embolic Microspheres Sales by Country (2019-2024)
7.1.2 Europe TACE Embolic Microspheres Revenue by Country (2019-2024)
7.2 Europe TACE Embolic Microspheres Sales by Type (2019-2024)
7.3 Europe TACE Embolic Microspheres Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TACE Embolic Microspheres by Country
8.1.1 Middle East & Africa TACE Embolic Microspheres Sales by Country (2019-2024)
8.1.2 Middle East & Africa TACE Embolic Microspheres Revenue by Country (2019-2024)
8.2 Middle East & Africa TACE Embolic Microspheres Sales by Type (2019-2024)
8.3 Middle East & Africa TACE Embolic Microspheres Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TACE Embolic Microspheres
10.3 Manufacturing Process Analysis of TACE Embolic Microspheres
10.4 Industry Chain Structure of TACE Embolic Microspheres
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TACE Embolic Microspheres Distributors
11.3 TACE Embolic Microspheres Customer
12 WORLD FORECAST REVIEW FOR TACE EMBOLIC MICROSPHERES BY GEOGRAPHIC REGION
12.1 Global TACE Embolic Microspheres Market Size Forecast by Region
12.1.1 Global TACE Embolic Microspheres Forecast by Region (2025-2030)
12.1.2 Global TACE Embolic Microspheres Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global TACE Embolic Microspheres Forecast by Type (2025-2030)
12.7 Global TACE Embolic Microspheres Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific TACE Embolic Microspheres Product Portfolios and Specifications
13.1.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Terumo
13.2.1 Terumo Company Information
13.2.2 Terumo TACE Embolic Microspheres Product Portfolios and Specifications
13.2.3 Terumo TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Terumo Main Business Overview
13.2.5 Terumo Latest Developments
13.3 Merit Medical
13.3.1 Merit Medical Company Information
13.3.2 Merit Medical TACE Embolic Microspheres Product Portfolios and Specifications
13.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merit Medical Main Business Overview
13.3.5 Merit Medical Latest Developments
13.4 Varian
13.4.1 Varian Company Information
13.4.2 Varian TACE Embolic Microspheres Product Portfolios and Specifications
13.4.3 Varian TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Varian Main Business Overview
13.4.5 Varian Latest Developments
13.5 Sirtex Medical
13.5.1 Sirtex Medical Company Information
13.5.2 Sirtex Medical TACE Embolic Microspheres Product Portfolios and Specifications
13.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sirtex Medical Main Business Overview
13.5.5 Sirtex Medical Latest Developments
13.6 Suzhou Hengrui Medical Equipment
13.6.1 Suzhou Hengrui Medical Equipment Company Information
13.6.2 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolios and Specifications
13.6.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Suzhou Hengrui Medical Equipment Main Business Overview
13.6.5 Suzhou Hengrui Medical Equipment Latest Developments
13.7 ABK Biomedical
13.7.1 ABK Biomedical Company Information
13.7.2 ABK Biomedical TACE Embolic Microspheres Product Portfolios and Specifications
13.7.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 ABK Biomedical Main Business Overview
13.7.5 ABK Biomedical Latest Developments
13.8 Mermaid Medical
13.8.1 Mermaid Medical Company Information
13.8.2 Mermaid Medical TACE Embolic Microspheres Product Portfolios and Specifications
13.8.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Mermaid Medical Main Business Overview
13.8.5 Mermaid Medical Latest Developments
13.9 Cardiolink Science
13.9.1 Cardiolink Science Company Information
13.9.2 Cardiolink Science TACE Embolic Microspheres Product Portfolios and Specifications
13.9.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cardiolink Science Main Business Overview
13.9.5 Cardiolink Science Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1.TACE Embolic Microspheres Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2.TACE Embolic Microspheres Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Common Embolic Microspheres
Table 4. Major Players of Drug-Loadable Embolic Microspheres
Table 5. GlobalTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 6. GlobalTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Table 7. GlobalTACE Embolic Microspheres Revenue byType (2019-2024) & ($ million)
Table 8. GlobalTACE Embolic Microspheres Revenue Market Share byType (2019-2024)
Table 9. GlobalTACE Embolic Microspheres Sale Price byType (2019-2024) & (US$/Unit)
Table 10. GlobalTACE Embolic Microspheres Sale by Application (2019-2024) & (K Units)
Table 11. GlobalTACE Embolic Microspheres Sale Market Share by Application (2019-2024)
Table 12. GlobalTACE Embolic Microspheres Revenue by Application (2019-2024) & ($ million)
Table 13. GlobalTACE Embolic Microspheres Revenue Market Share by Application (2019-2024)
Table 14. GlobalTACE Embolic Microspheres Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. GlobalTACE Embolic Microspheres Sales by Company (2019-2024) & (K Units)
Table 16. GlobalTACE Embolic Microspheres Sales Market Share by Company (2019-2024)
Table 17. GlobalTACE Embolic Microspheres Revenue by Company (2019-2024) & ($ millions)
Table 18. GlobalTACE Embolic Microspheres Revenue Market Share by Company (2019-2024)
Table 19. GlobalTACE Embolic Microspheres Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key ManufacturersTACE Embolic Microspheres Producing Area Distribution and Sales Area
Table 21. PlayersTACE Embolic Microspheres Products Offered
Table 22.TACE Embolic Microspheres Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalTACE Embolic Microspheres Sales by Geographic Region (2019-2024) & (K Units)
Table 26. GlobalTACE Embolic Microspheres Sales Market Share Geographic Region (2019-2024)
Table 27. GlobalTACE Embolic Microspheres Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. GlobalTACE Embolic Microspheres Revenue Market Share by Geographic Region (2019-2024)
Table 29. GlobalTACE Embolic Microspheres Sales by Country/Region (2019-2024) & (K Units)
Table 30. GlobalTACE Embolic Microspheres Sales Market Share by Country/Region (2019-2024)
Table 31. GlobalTACE Embolic Microspheres Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. GlobalTACE Embolic Microspheres Revenue Market Share by Country/Region (2019-2024)
Table 33. AmericasTACE Embolic Microspheres Sales by Country (2019-2024) & (K Units)
Table 34. AmericasTACE Embolic Microspheres Sales Market Share by Country (2019-2024)
Table 35. AmericasTACE Embolic Microspheres Revenue by Country (2019-2024) & ($ millions)
Table 36. AmericasTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 37. AmericasTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 38. APACTACE Embolic Microspheres Sales by Region (2019-2024) & (K Units)
Table 39. APACTACE Embolic Microspheres Sales Market Share by Region (2019-2024)
Table 40. APACTACE Embolic Microspheres Revenue by Region (2019-2024) & ($ millions)
Table 41. APACTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 42. APACTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 43. EuropeTACE Embolic Microspheres Sales by Country (2019-2024) & (K Units)
Table 44. EuropeTACE Embolic Microspheres Revenue by Country (2019-2024) & ($ millions)
Table 45. EuropeTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 46. EuropeTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & AfricaTACE Embolic Microspheres Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & AfricaTACE Embolic Microspheres Revenue Market Share by Country (2019-2024)
Table 49. Middle East & AfricaTACE Embolic Microspheres Sales byType (2019-2024) & (K Units)
Table 50. Middle East & AfricaTACE Embolic Microspheres Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities ofTACE Embolic Microspheres
Table 52. Key Market Challenges & Risks ofTACE Embolic Microspheres
Table 53. Key IndustryTrends ofTACE Embolic Microspheres
Table 54.TACE Embolic Microspheres Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.TACE Embolic Microspheres Distributors List
Table 57.TACE Embolic Microspheres Customer List
Table 58. GlobalTACE Embolic Microspheres SalesForecast by Region (2025-2030) & (K Units)
Table 59. GlobalTACE Embolic Microspheres RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. AmericasTACE Embolic Microspheres SalesForecast by Country (2025-2030) & (K Units)
Table 61. AmericasTACE Embolic Microspheres Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APACTACE Embolic Microspheres SalesForecast by Region (2025-2030) & (K Units)
Table 63. APACTACE Embolic Microspheres Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. EuropeTACE Embolic Microspheres SalesForecast by Country (2025-2030) & (K Units)
Table 65. EuropeTACE Embolic Microspheres RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & AfricaTACE Embolic Microspheres SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & AfricaTACE Embolic Microspheres RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. GlobalTACE Embolic Microspheres SalesForecast byType (2025-2030) & (K Units)
Table 69. GlobalTACE Embolic Microspheres RevenueForecast byType (2025-2030) & ($ millions)
Table 70. GlobalTACE Embolic Microspheres SalesForecast by Application (2025-2030) & (K Units)
Table 71. GlobalTACE Embolic Microspheres RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. Boston Scientific Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 73. Boston ScientificTACE Embolic Microspheres Product Portfolios and Specifications
Table 74. Boston ScientificTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Boston Scientific Main Business
Table 76. Boston Scientific Latest Developments
Table 77.Terumo Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 78.TerumoTACE Embolic Microspheres Product Portfolios and Specifications
Table 79.TerumoTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80.Terumo Main Business
Table 81.Terumo Latest Developments
Table 82. Merit Medical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 83. Merit MedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 84. Merit MedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Merit Medical Main Business
Table 86. Merit Medical Latest Developments
Table 87. Varian Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 88. VarianTACE Embolic Microspheres Product Portfolios and Specifications
Table 89. VarianTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Varian Main Business
Table 91. Varian Latest Developments
Table 92. Sirtex Medical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 93. Sirtex MedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 94. Sirtex MedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sirtex Medical Main Business
Table 96. Sirtex Medical Latest Developments
Table 97. Suzhou Hengrui Medical Equipment Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 98. Suzhou Hengrui Medical EquipmentTACE Embolic Microspheres Product Portfolios and Specifications
Table 99. Suzhou Hengrui Medical EquipmentTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Suzhou Hengrui Medical Equipment Main Business
Table 101. Suzhou Hengrui Medical Equipment Latest Developments
Table 102. ABK Biomedical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 103. ABK BiomedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 104. ABK BiomedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. ABK Biomedical Main Business
Table 106. ABK Biomedical Latest Developments
Table 107. Mermaid Medical Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 108. Mermaid MedicalTACE Embolic Microspheres Product Portfolios and Specifications
Table 109. Mermaid MedicalTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Mermaid Medical Main Business
Table 111. Mermaid Medical Latest Developments
Table 112. Cardiolink Science Basic Information,TACE Embolic Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 113. Cardiolink ScienceTACE Embolic Microspheres Product Portfolios and Specifications
Table 114. Cardiolink ScienceTACE Embolic Microspheres Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Cardiolink Science Main Business
Table 116. Cardiolink Science Latest Developments
LIST OFFIGURES
.
Figure 1. Picture ofTACE Embolic Microspheres
Figure 2.TACE Embolic Microspheres Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTACE Embolic Microspheres Sales Growth Rate 2019-2030 (K Units)
Figure 7. GlobalTACE Embolic Microspheres Revenue Growth Rate 2019-2030 ($ millions)
Figure 8.TACE Embolic Microspheres Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9.TACE Embolic Microspheres Sales Market Share by Country/Region (2023)
Figure 10.TACE Embolic Microspheres Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Common Embolic Microspheres
Figure 12. Product Picture of Drug-Loadable Embolic Microspheres
Figure 13. GlobalTACE Embolic Microspheres Sales Market Share byType in 2023
Figure 14. GlobalTACE Embolic Microspheres Revenue Market Share byType (2019-2024)
Figure 15.TACE Embolic Microspheres Consumed in Primary Liver Cancer
Figure 16. GlobalTACE Embolic Microspheres Market: Primary Liver Cancer (2019-2024) & (K Units)
Figure 17.TACE Embolic Microspheres Consumed in Colorectal Cancer Liver Metastasis
Figure 18. GlobalTACE Embolic Microspheres Market: Colorectal Cancer Liver Metastasis (2019-2024) & (K Units)
Figure 19.TACE Embolic Microspheres Consumed in Others
Figure 20. GlobalTACE Embolic Microspheres Market: Others (2019-2024) & (K Units)
Figure 21. GlobalTACE Embolic Microspheres Sale Market Share by Application (2023)
Figure 22. GlobalTACE Embolic Microspheres Revenue Market Share by Application in 2023
Figure 23.TACE Embolic Microspheres Sales by Company in 2023 (K Units)
Figure 24. GlobalTACE Embolic Microspheres Sales Market Share by Company in 2023
Figure 25.TACE Embolic Microspheres Revenue by Company in 2023 ($ millions)
Figure 26. GlobalTACE Embolic Microspheres Revenue Market Share by Company in 2023
Figure 27. GlobalTACE Embolic Microspheres Sales Market Share by Geographic Region (2019-2024)
Figure 28. GlobalTACE Embolic Microspheres Revenue Market Share by Geographic Region in 2023
Figure 29. AmericasTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 30. AmericasTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 31. APACTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 32. APACTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 33. EuropeTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 34. EuropeTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 35. Middle East & AfricaTACE Embolic Microspheres Sales 2019-2024 (K Units)
Figure 36. Middle East & AfricaTACE Embolic Microspheres Revenue 2019-2024 ($ millions)
Figure 37. AmericasTACE Embolic Microspheres Sales Market Share by Country in 2023
Figure 38. AmericasTACE Embolic Microspheres Revenue Market Share by Country (2019-2024)
Figure 39. AmericasTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 40. AmericasTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 41. United StatesTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 42. CanadaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 43. MexicoTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 44. BrazilTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 45. APACTACE Embolic Microspheres Sales Market Share by Region in 2023
Figure 46. APACTACE Embolic Microspheres Revenue Market Share by Region (2019-2024)
Figure 47. APACTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 48. APACTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 49. ChinaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 50. JapanTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 51. South KoreaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast AsiaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 53. IndiaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 54. AustraliaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwanTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 56. EuropeTACE Embolic Microspheres Sales Market Share by Country in 2023
Figure 57. EuropeTACE Embolic Microspheres Revenue Market Share by Country (2019-2024)
Figure 58. EuropeTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 59. EuropeTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 60. GermanyTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 61.FranceTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 62. UKTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 63. ItalyTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 64. RussiaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & AfricaTACE Embolic Microspheres Sales Market Share by Country (2019-2024)
Figure 66. Middle East & AfricaTACE Embolic Microspheres Sales Market Share byType (2019-2024)
Figure 67. Middle East & AfricaTACE Embolic Microspheres Sales Market Share by Application (2019-2024)
Figure 68. EgyptTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 69. South AfricaTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 70. IsraelTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 71.TurkeyTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC CountriesTACE Embolic Microspheres Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofTACE Embolic Microspheres in 2023
Figure 74. Manufacturing Process Analysis ofTACE Embolic Microspheres
Figure 75. Industry Chain Structure ofTACE Embolic Microspheres
Figure 76. Channels of Distribution
Figure 77. GlobalTACE Embolic Microspheres Sales MarketForecast by Region (2025-2030)
Figure 78. GlobalTACE Embolic Microspheres Revenue Market ShareForecast by Region (2025-2030)
Figure 79. GlobalTACE Embolic Microspheres Sales Market ShareForecast byType (2025-2030)
Figure 80. GlobalTACE Embolic Microspheres Revenue Market ShareForecast byType (2025-2030)
Figure 81. GlobalTACE Embolic Microspheres Sales Market ShareForecast by Application (2025-2030)
Figure 82. GlobalTACE Embolic Microspheres Revenue Market ShareForecast by Application (2025-2030)
